Literature DB >> 3918615

Epidemiological characteristics of platelet aggregability.

T W Meade, M V Vickers, S G Thompson, Y Stirling, A P Haines, G J Miller.   

Abstract

The epidemiological characteristics of platelet aggregability were established in 958 participants in the Northwick Park Heart Study. The main analyses were based on the dose of adenosine diphosphate at which primary aggregation occurred at half its maximum velocity. Aggregability increased with age in both sexes, was greater in whites than blacks (particularly among men), and tended to decrease with the level of habitual alcohol consumption. Aggregability was, however, greater in women than men and in nonsmokers than smokers. There was no relation between aggregability on the one hand and obesity, current or past oral contraceptive use, menopausal state, or blood cholesterol and triglyceride concentrations on the other. Aggregability was somewhat, though not significantly, higher in men with a history of ischaemic heart disease and in those with electrocardiographic evidence of ischaemia than in those without. There was a strong association between the plasma fibrinogen concentration and aggregability. The widely held concept of platelet aggregability and its implications is probably an oversimplification. In the prevention of thrombosis it may be as useful to consider modifying external influences on platelet behaviour, such as plasma fibrinogen concentration or thrombin production, as it is to rely solely on platelet active agents.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918615      PMCID: PMC1417797          DOI: 10.1136/bmj.290.6466.428

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  27 in total

1.  Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments.

Authors:  D M Tollefsen; P W Majerus
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

2.  Sex and age differences in human platelet aggregation.

Authors:  M Johnson; E Ramey; P W Ramwell
Journal:  Nature       Date:  1975-01-31       Impact factor: 49.962

3.  Smoking, platelets and thrombosis.

Authors:  R I Hawkins
Journal:  Nature       Date:  1972-04-28       Impact factor: 49.962

4.  The effect of ethanol on hemostatic properties of human blood platelets.

Authors:  M J Haut; D H Cowan
Journal:  Am J Med       Date:  1974-01       Impact factor: 4.965

5.  Platelet function in hyperlipoproteinemia.

Authors:  A C Carvalho; R W Colman; R S Lees
Journal:  N Engl J Med       Date:  1974-02-21       Impact factor: 91.245

6.  An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis.

Authors:  P H Levine
Journal:  Circulation       Date:  1973-09       Impact factor: 29.690

7.  Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication.

Authors:  J A Dormandy; E Hoare; J Colley; D E Arrowsmith; T L Dormandy
Journal:  Br Med J       Date:  1973-12-08

Review 8.  Alcohol and coronary heart disease.

Authors:  M G Marmot
Journal:  Int J Epidemiol       Date:  1984-06       Impact factor: 7.196

9.  An epidemiological study of the haemostatic and other effects of oral contraceptives.

Authors:  T W Meade; M Brozović; R Chakrabarth; D J Howarth; W R North; Y Stirling
Journal:  Br J Haematol       Date:  1976-11       Impact factor: 6.998

10.  Fibrinogen as a risk factor for stroke and myocardial infarction.

Authors:  L Wilhelmsen; K Svärdsudd; K Korsan-Bengtsen; B Larsson; L Welin; G Tibblin
Journal:  N Engl J Med       Date:  1984-08-23       Impact factor: 91.245

View more
  37 in total

Review 1.  Cardiovascular effects of alcohol.

Authors:  D M Davidson
Journal:  West J Med       Date:  1989-10

2.  Trans fat, aspirin, and ischemic stroke in postmenopausal women.

Authors:  Sirin Yaemsiri; Souvik Sen; Lesley Tinker; Wayne Rosamond; Sylvia Wassertheil-Smoller; Ka He
Journal:  Ann Neurol       Date:  2012-03-01       Impact factor: 10.422

Review 3.  The Jeremiah Metzger lecture. Participation of eicosanoids in the syndromes of myocardial ischemia.

Authors:  J A Oates
Journal:  Trans Am Clin Climatol Assoc       Date:  1990

4.  Gender, race and diet affect platelet function tests in normal subjects, contributing to a high rate of abnormal results.

Authors:  Connie H Miller; Anne S Rice; Katherine Garrett; Sidney F Stein
Journal:  Br J Haematol       Date:  2014-03-12       Impact factor: 6.998

5.  Small subcortical infarcts and primary subcortical haemorrhages may have different risk factors.

Authors:  E Janssens; F Mounier-Vehier; M Hamon; D Leys
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

6.  Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from healthy habitual cigarette smokers.

Authors:  T Imaizumi; K Satoh; H Yoshida; Y Kawamura; M Hiramoto; M Koyanagi; S Takamatsu; M Takamatsu
Journal:  Heart Vessels       Date:  1990       Impact factor: 2.037

7.  Effects of age, sex and the oral contraceptive on the platelet membrane fibrinogen binding site (glycoprotein IIb/IIIa).

Authors:  M Cahill; R Mistry; C Chapman; J K Wood; D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

8.  The effects of varying doses of aspirin on human platelet activation induced by PAF, collagen and arachidonic acid.

Authors:  M L Taylor; N L Misso; G A Stewart; P J Thompson
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

9.  Strenuous exercise, plasma fibrinogen, and factor VII activity.

Authors:  J B Connelly; J A Cooper; T W Meade
Journal:  Br Heart J       Date:  1992-05

10.  Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease.

Authors:  D P Mikhailidis; M A Barradas; A Maris; J Y Jeremy; P Dandona
Journal:  J Clin Pathol       Date:  1985-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.